#immunosym

1 stories · following the connections

Business

Biothera Pharmaceuticals Announces Presentation of Clinical Data Supporting Use of a Patient Selection Biomarker for its Phase 2 Cancer Immunotherapy

By Nasdaq OMXFeb 24, 2017, 7:24 PM UTC